Mahanta P J, Agarawalla Bishal, Sharma Manjuri
Department of Nephrology, Gauhati Medical College and Hospital, Guwahati, Assam, India.
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):445-450. doi: 10.4103/1319-2442.256851.
The aim of this study is to investigate the distinctive clinicopathological characteristics of acute kidney injury (AKI) in immunoglobulin A (IgA) nephropathy and identify the possible risk factors for AKI in IgA nephropathy. This study was a hospital-based retrospective analysis of clinicopthological data of IgA nephropathy. The study was conducted in the Department of Nephrology, Gauhati Medical College and Hospital, Assam, India from the period from January 2012 to December 2016. A total of 169 patients who met the inclusion or exclusion criteria were included in the study. Patient data (clinical/demographic and laboratory data including renal biopsy) were collected and were analyzed to assess the risk factors for AKI in IgA nephropathy. For the purpose of analyses, the patients were divided into two groups, AKI (n = 28) and non-AKI group (n = 141). Twenty-eight patients out of 169 developed AKI. The prevalence of AKI in IgA nephropathy patients in our center was 16.5% (28/169). Most AKI patients were hypertensive, hyperlipidemic, had pre-existing impaired kidney function, and higher baseline serum creatinine, higher serum uric acid, and proteinuria, with lower serum albumin and hemoglobin (P <0.05). Use of herbal medications was also significantly more common in the AKI group (P <0.003). Pathological features, like crescents (both cellular and fibrocellular) and interstitial fibrosis/tubular atrophy, were also more severe in the AKI group (P <0.003). In multivariate logistic regression analysis, we found that hypertension, proteinuria, cellular and fibro-cellular crescents, glomerular sclerosis were possible risk factors for AKI. Prevalence of AKI in IgA nephropathy is not as uncommon in north-eastern India as previously thought and knowledge of risk factors for AKI can help in early identification of individuals at risk.
本研究旨在探讨免疫球蛋白A(IgA)肾病中急性肾损伤(AKI)独特的临床病理特征,并确定IgA肾病患者发生AKI的可能危险因素。本研究是基于医院对IgA肾病临床病理数据的回顾性分析。该研究于2012年1月至2016年12月在印度阿萨姆邦高哈蒂医学院和医院的肾病科进行。共有169例符合纳入或排除标准的患者被纳入研究。收集患者数据(临床/人口统计学和实验室数据,包括肾活检)并进行分析,以评估IgA肾病患者发生AKI的危险因素。为便于分析,将患者分为两组,即AKI组(n = 28)和非AKI组(n = 141)。169例患者中有28例发生了AKI。我们中心IgA肾病患者中AKI的患病率为16.5%(28/169)。大多数AKI患者患有高血压、高脂血症,存在肾功能损害,基线血清肌酐、血清尿酸较高,蛋白尿阳性,血清白蛋白和血红蛋白较低(P <0.05)。在AKI组中使用草药药物也明显更为常见(P <0.003)。AKI组的病理特征,如新月体(细胞性和纤维细胞性)以及间质纤维化/肾小管萎缩也更为严重(P <0.003)。在多因素逻辑回归分析中,我们发现高血压、蛋白尿、细胞性和纤维细胞性新月体、肾小球硬化是AKI的可能危险因素。在印度东北部,IgA肾病中AKI的患病率并不像以前认为的那样罕见,了解AKI的危险因素有助于早期识别高危个体。